Portal de Periódicos da CAPES

Thiamine‐responsive megaloblastic anemia with diabetes mellitus and sensorineural deafness

1993; Wiley; Volume: 35; Issue: 3 Linguagem: Inglês

10.1111/j.1442-200x.1993.tb03049.x

1442-200X

Ayşehan Akıncı, Tahsin Teziç, G Ertürk, Ömer Tarım, Klara Dalva,

Metabolism and Genetic Disorders

Abstract This study introduces a patient who has thiamine and thiamine pyrophosphokinase (TPKase) enzyme deficiency associated with diabetes mellitus, sensorineural deafness and thiamine‐responsive megaloblastic anemia. Diabetes mellitus was diagnosed when she was 20 months old. After 1 year, macrocytic anemia developed and the thiamine therapy was started at 75 mg/day. During the follow‐up, the insulin requirement decreased and even ceased, and macrocytic anemia improved with thiamine treatment. After thiamine therapy was ceased an increase in insulin requirement was observed and macrocytic anemia developed again.